Published in PLoS One on April 03, 2017
Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest (2004) 13.42
Three-point Dixon technique for true water/fat decomposition with B0 inhomogeneity correction. Magn Reson Med (1991) 5.06
Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet (2009) 4.96
Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure. Cell (2012) 4.88
Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci U S A (1994) 4.01
Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia (2011) 3.97
Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med (2007) 3.88
In vivo characterization of the liver fat ¹H MR spectrum. NMR Biomed (2010) 3.07
Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest (1994) 2.76
Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care (2007) 2.61
Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat (2007) 2.58
Water-fat separation with IDEAL gradient-echo imaging. J Magn Reson Imaging (2007) 2.56
Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut (2011) 2.38
Pancreatic adipose tissue infiltration, parenchymal steatosis and beta cell function in humans. Diabetologia (2015) 2.11
Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat. Clin Endocrinol (Oxf) (2015) 2.01
Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans. Obesity (Silver Spring) (2009) 1.70
Mode of onset of type 2 diabetes from normal or impaired glucose tolerance. Diabetes (2004) 1.53
Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab (2009) 1.44
Obesity and fat quantification in lean tissues using three-point Dixon MR imaging. Pediatr Radiol (2005) 1.31
Uneven fatty replacement of the pancreas: evaluation with CT. Radiology (1995) 1.30
Focal fatty replacement of the pancreas: usefulness of chemical shift MRI. AJR Am J Roentgenol (2007) 1.27
Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev (2010) 1.27
Chronic perifusion of rat islets with palmitate suppresses glucose-stimulated insulin release. Endocrinology (1993) 1.25
Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques. Invest Radiol (2008) 1.21
Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolism. J Clin Endocrinol Metab (2010) 1.16
Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2013) 1.15
Pancreatic triacylglycerol distribution in type 2 diabetes. Diabetologia (2015) 1.14
Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity (Silver Spring) (2008) 1.14
Ethnic differences in pancreatic fat accumulation and its relationship with other fat depots and inflammatory markers. Diabetes Care (2011) 1.09
MRI-determined fat content of human liver, pancreas and kidney. World J Gastroenterol (2010) 1.04
Peroxisome proliferator-activated receptor alpha improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets. Diabetes (2006) 1.02
Fatty pancreas, insulin resistance, and β-cell function: a population study using fat-water magnetic resonance imaging. Am J Gastroenterol (2014) 0.99
The association between nonalcoholic fatty pancreas disease and diabetes. PLoS One (2013) 0.97
Pancreatic steatosis and its relationship to β-cell dysfunction in humans: racial and ethnic variations. Diabetes Care (2012) 0.97
Focal fatty infiltration of the pancreas: MR characterization with chemical shift imaging. AJR Am J Roentgenol (1999) 0.92
Ectopic fat storage in the pancreas using 1H-MRS: importance of diabetic status and modulation with bariatric surgery-induced weight loss. Int J Obes (Lond) (2014) 0.90
Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls. Gastroenterol Res Pract (2013) 0.88
Noninvasive quantification of pancreatic fat in healthy male population using chemical shift magnetic resonance imaging: effect of aging on pancreatic fat content. Pancreas (2011) 0.87
Morphology of the pancreas in type 2 diabetes: effect of weight loss with or without normalisation of insulin secretory capacity. Diabetologia (2016) 0.87
Pancreatic steatosis: Is it related to either obesity or diabetes mellitus? World J Diabetes (2014) 0.86
Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders. Diabetes Care (2016) 0.86
Altered volume, morphology and composition of the pancreas in type 2 diabetes. PLoS One (2015) 0.85
Pancreatic fat accumulation and its relationship with liver fat content and other fat depots in obese individuals. J Endocrinol Invest (2011) 0.82
Pancreatic Steatosis Demonstrated at MR Imaging in the General Population: Clinical Relevance. Radiology (2015) 0.82
Accelerating MR Imaging Liver Steatosis Measurement Using Combined Compressed Sensing and Parallel Imaging: A Quantitative Evaluation. Radiology (2015) 0.82
Weight Loss Decreases Excess Pancreatic Triacylglycerol Specifically in Type 2 Diabetes. Diabetes Care (2015) 0.81
Insulin secretion after short- and long-term low-grade free fatty acid infusion in men with increased risk of developing type 2 diabetes. Metabolism (2003) 0.81
Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease. Abdom Imaging (2015) 0.80
Initial clinical application of modified Dixon with flexible echo times: hepatic and pancreatic fat assessments in comparison with (1)H MRS. MAGMA (2013) 0.80
Quantitative assessment of pancreatic fat by using unenhanced CT: pathologic correlation and clinical implications. Radiology (2014) 0.80
Effect of modest caloric restriction on oxidative stress in women, a randomized trial. PLoS One (2012) 0.80
Whole-body continuously moving table fat-water MRI with dynamic B0 shimming at 3 Tesla. Magn Reson Med (2015) 0.79
Ectopic fat in youth: the contribution of hepatic and pancreatic fat to metabolic disturbances. Obesity (Silver Spring) (2014) 0.79
Detection of hepatic and pancreatic fat infiltration in type II diabetes mellitus patients with IDEAL-Quant using 3.0T MR: comparison with single-voxel proton spectroscopy. Chin Med J (Engl) (2014) 0.78
Type 2 Diabetes: The Pathologic Basis of Reversible β-Cell Dysfunction. Diabetes Care (2016) 0.78
Reversibility of metabolic and morphological changes associated with chronic exposure of pancreatic islet beta-cells to fatty acids. J Cell Biochem (2010) 0.78
MRI chemical shift imaging of the fat content of the pancreas and liver of patients with type 2 diabetes mellitus. Exp Ther Med (2015) 0.78
Pancreatic Lipid Content Is Not Associated with Beta Cell Dysfunction in Youth-Onset Type 2 Diabetes. Can J Diabetes (2015) 0.76
Multisite, multivendor validation of the accuracy and reproducibility of proton-density fat-fraction quantification at 1.5T and 3T using a fat-water phantom. Magn Reson Med (2016) 0.76
Pancreatic triacylglycerol distribution in type 2 diabetes. Reply to Hollingsworth K. G., Al Mrabeh A., Steven S. et al [letter]. Diabetologia (2015) 0.76
Pancreatic fat and hepato-metabolic features in obese children with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf) (2015) 0.76